Skip to main content
Erschienen in: International Orthopaedics 9/2014

01.09.2014 | Original Paper

Local transplantation is an effective method for cell delivery in the osteogenesis imperfecta murine model

verfasst von: Penelope Pauley, Brya G. Matthews, Liping Wang, Nathaniel A. Dyment, Igor Matic, David W. Rowe, Ivo Kalajzic

Erschienen in: International Orthopaedics | Ausgabe 9/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Osteogenesis imperfecta is a serious genetic disorder that results from improper type I collagen production. We aimed to evaluate whether bone marrow stromal cells (BMSC) delivered locally into femurs were able to engraft, differentiate into osteoblasts, and contribute to formation of normal bone matrix in the osteogenesis imperfect murine (oim) model.

Methods

Donor BMSCs from bone-specific reporter mice (Col2.3GFP) were expanded in vitro and transplanted into the femoral intramedullary cavity of oim mice. Engraftment was evaluated after four weeks.

Results

We detected differentiation of donor BMSCs into Col2.3GFP+ osteoblasts and osteocytes in cortical and trabecular bone of transplanted oim femurs. New bone formation was detected by deposition of dynamic label in the proximity to the Col2.3GFP+ osteoblasts, and new bone showed more organized collagen structure and expression of type I α2 collagen. Col2.3GFP cells were not found in the contralateral femur indicating that transplanted osteogenic cells did not disseminate by circulation. No osteogenic engraftment was observed following intravenous transplantation of BMSCs. BMSC cultures derived from transplanted femurs showed numerous Col2.3GFP+ colonies, indicating the presence of donor progenitor cells. Secondary transplantation of cells recovered from recipient femurs and expanded in vitro also showed Col2.3GFP+ osteoblasts and osteocytes confirming the persistence of donor stem/progenitor cells.

Conclusion

We show that BMSCs delivered locally in oim femurs are able to engraft, differentiate into osteoblasts and osteocytes and maintain their progenitor potential in vivo. This suggests that local delivery is a promising approach for introduction of autologous MSC in which mutations have been corrected.
Literatur
2.
Zurück zum Zitat Chamberlain JR, Schwarze U, Wang PR, Hirata RK, Hankenson KD, Pace JM, Underwood RA, Song KM, Sussman M, Byers PH, Russell DW (2004) Gene targeting in stem cells from individuals with osteogenesis imperfecta. Science 303:1198–1201PubMedCrossRef Chamberlain JR, Schwarze U, Wang PR, Hirata RK, Hankenson KD, Pace JM, Underwood RA, Song KM, Sussman M, Byers PH, Russell DW (2004) Gene targeting in stem cells from individuals with osteogenesis imperfecta. Science 303:1198–1201PubMedCrossRef
3.
Zurück zum Zitat Prockop DJ, Oh JY (2012) Medical therapies with adult stem/progenitor cells (MSCs): a backward journey from dramatic results in vivo to the cellular and molecular explanations. J Cell Biochem 113:1460–1469PubMedCentralPubMed Prockop DJ, Oh JY (2012) Medical therapies with adult stem/progenitor cells (MSCs): a backward journey from dramatic results in vivo to the cellular and molecular explanations. J Cell Biochem 113:1460–1469PubMedCentralPubMed
4.
Zurück zum Zitat Boban I, Jacquin C, Prior K, Barisic-Dujmovic T, Maye P, Clark SH, Aguila HL (2006) The 3.6 kb DNA fragment from the rat Col1a1 gene promoter drives the expression of genes in both osteoblast and osteoclast lineage cells. Bone 39:1302–1312PubMedCrossRef Boban I, Jacquin C, Prior K, Barisic-Dujmovic T, Maye P, Clark SH, Aguila HL (2006) The 3.6 kb DNA fragment from the rat Col1a1 gene promoter drives the expression of genes in both osteoblast and osteoclast lineage cells. Bone 39:1302–1312PubMedCrossRef
5.
Zurück zum Zitat Boban I, Barisic-Dujmovic T, Clark SH (2010) Parabiosis model does not show presence of circulating osteoprogenitor cells. Genesis 48:171–182PubMed Boban I, Barisic-Dujmovic T, Clark SH (2010) Parabiosis model does not show presence of circulating osteoprogenitor cells. Genesis 48:171–182PubMed
6.
Zurück zum Zitat Wang LP, Liu YL, Kalajzic Z, Jiang X, Rowe DW (2005) Heterogeneity of engrafted bone-lining cells after systemic and local transplantation. Blood 106:3650–3657PubMedCentralPubMedCrossRef Wang LP, Liu YL, Kalajzic Z, Jiang X, Rowe DW (2005) Heterogeneity of engrafted bone-lining cells after systemic and local transplantation. Blood 106:3650–3657PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat Vanleene M, Saldanha Z, Cloyd KL, Jell G, Bou-Gharios G, Bassett JHD, Williams GR, Fisk NM, Oyen ML, Stevens MM, Guillot PV, Shefelbine SJ (2011) Transplantation of human fetal blood stem cells in the osteogenesis imperfecta mouse leads to improvement in multiscale tissue properties. Blood 117:1053–1060PubMedCrossRef Vanleene M, Saldanha Z, Cloyd KL, Jell G, Bou-Gharios G, Bassett JHD, Williams GR, Fisk NM, Oyen ML, Stevens MM, Guillot PV, Shefelbine SJ (2011) Transplantation of human fetal blood stem cells in the osteogenesis imperfecta mouse leads to improvement in multiscale tissue properties. Blood 117:1053–1060PubMedCrossRef
8.
Zurück zum Zitat Guillot PV, Abass O, Bassett JH, Shefelbine SJ, Bou-Gharios G, Chan J, Kurata H, Williams GR, Polak J, Fisk NM (2008) Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice. Blood 111:1717–1725PubMedCrossRef Guillot PV, Abass O, Bassett JH, Shefelbine SJ, Bou-Gharios G, Chan J, Kurata H, Williams GR, Polak J, Fisk NM (2008) Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice. Blood 111:1717–1725PubMedCrossRef
9.
Zurück zum Zitat Panaroni C, Gioia R, Lupi A, Besio R, Goldstein SA, Kreider J, Leikin S, Vera JC, Mertz EL, Perilli E, Baruffaldi F, Villa I, Farina A, Casasco M, Cetta G, Rossi A, Frattini A, Marini JC, Vezzoni P, Forlino A (2009) In utero transplantation of adult bone marrow decreases perinatal lethality and rescues the bone phenotype in the knockin murine model for classical, dominant osteogenesis imperfecta. Blood 114:459–468PubMedCentralPubMedCrossRef Panaroni C, Gioia R, Lupi A, Besio R, Goldstein SA, Kreider J, Leikin S, Vera JC, Mertz EL, Perilli E, Baruffaldi F, Villa I, Farina A, Casasco M, Cetta G, Rossi A, Frattini A, Marini JC, Vezzoni P, Forlino A (2009) In utero transplantation of adult bone marrow decreases perinatal lethality and rescues the bone phenotype in the knockin murine model for classical, dominant osteogenesis imperfecta. Blood 114:459–468PubMedCentralPubMedCrossRef
10.
Zurück zum Zitat Pereira RF, O'Hara MD, Laptev AV, Halford KW, Pollard MD, Class R, Simon D, Livezey K, Prockop DJ (1998) Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proc Natl Acad Sci USA 95:1142–1147PubMedCentralPubMedCrossRef Pereira RF, O'Hara MD, Laptev AV, Halford KW, Pollard MD, Class R, Simon D, Livezey K, Prockop DJ (1998) Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proc Natl Acad Sci USA 95:1142–1147PubMedCentralPubMedCrossRef
11.
Zurück zum Zitat Otsuru S, Gordon PL, Shimono K, Jethva R, Marino R, Phillips CL, Hofmann TJ, Veronesi E, Dominici M, Iwamoto M, Horwitz EM (2012) Transplanted bone marrow mononuclear cells and MSCs impart clinical benefit to children with osteogenesis imperfecta through different mechanisms. Blood 120:1933–1941PubMedCentralPubMedCrossRef Otsuru S, Gordon PL, Shimono K, Jethva R, Marino R, Phillips CL, Hofmann TJ, Veronesi E, Dominici M, Iwamoto M, Horwitz EM (2012) Transplanted bone marrow mononuclear cells and MSCs impart clinical benefit to children with osteogenesis imperfecta through different mechanisms. Blood 120:1933–1941PubMedCentralPubMedCrossRef
12.
Zurück zum Zitat Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M, Sussman M, Orchard P, Marx JC, Pyeritz RE, Brenner MK (1999) Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 5:309–313PubMedCrossRef Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M, Sussman M, Orchard P, Marx JC, Pyeritz RE, Brenner MK (1999) Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 5:309–313PubMedCrossRef
13.
Zurück zum Zitat Horwitz EM, Prockop DJ, Gordon PL, Koo WW, Fitzpatrick LA, Neel MD, McCarville ME, Orchard PJ, Pyeritz RE, Brenner MK (2001) Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 97:1227–1231PubMedCrossRef Horwitz EM, Prockop DJ, Gordon PL, Koo WW, Fitzpatrick LA, Neel MD, McCarville ME, Orchard PJ, Pyeritz RE, Brenner MK (2001) Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 97:1227–1231PubMedCrossRef
14.
Zurück zum Zitat Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, McNall RY, Muul L, Hofmann T (2002) Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA 99:8932–8937PubMedCentralPubMedCrossRef Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, McNall RY, Muul L, Hofmann T (2002) Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA 99:8932–8937PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat Kalajzic I, Kalajzic Z, Kaliterna M, Gronowicz G, Clark SH, Lichtler AC, Rowe D (2002) Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage. J Bone Miner Res 17:15–25PubMedCrossRef Kalajzic I, Kalajzic Z, Kaliterna M, Gronowicz G, Clark SH, Lichtler AC, Rowe D (2002) Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage. J Bone Miner Res 17:15–25PubMedCrossRef
16.
Zurück zum Zitat Saban J, King D (1996) PCR genotyping of oim mutant mice. Biotechniques 21(190):192 Saban J, King D (1996) PCR genotyping of oim mutant mice. Biotechniques 21(190):192
17.
Zurück zum Zitat Roguljic H, Matthews BG, Yang W, Cvija H, Mina M, Kalajzic I (2013) In vivo identification of periodontal progenitor cells. J Dent Res 92:709–715PubMedCentralPubMedCrossRef Roguljic H, Matthews BG, Yang W, Cvija H, Mina M, Kalajzic I (2013) In vivo identification of periodontal progenitor cells. J Dent Res 92:709–715PubMedCentralPubMedCrossRef
18.
Zurück zum Zitat Roberts-Pilgrim AM, Makareeva E, Myles MH, Besch-Williford CL, Brodeur AC, Walker AL, Leikin S, Franklin CL, Phillips CL (2011) Deficient degradation of homotrimeric type I collagen, alpha 1 (I)(3) glomerulopathy in oim mice. Mol Genet Metab 104:373–382PubMedCentralPubMedCrossRef Roberts-Pilgrim AM, Makareeva E, Myles MH, Besch-Williford CL, Brodeur AC, Walker AL, Leikin S, Franklin CL, Phillips CL (2011) Deficient degradation of homotrimeric type I collagen, alpha 1 (I)(3) glomerulopathy in oim mice. Mol Genet Metab 104:373–382PubMedCentralPubMedCrossRef
19.
Zurück zum Zitat Uveges TE, Kozloff KM, Ty JM, Ledgard F, Raggio CL, Gronowicz G, Goldstein SA, Marini JC (2009) Alendronate treatment of the brtl osteogenesis imperfecta mouse improves femoral geometry and load response before fracture but decreases predicted material properties and has detrimental effects on osteoblasts and bone formation. J Bone Miner Res 24:849–859PubMedCentralPubMedCrossRef Uveges TE, Kozloff KM, Ty JM, Ledgard F, Raggio CL, Gronowicz G, Goldstein SA, Marini JC (2009) Alendronate treatment of the brtl osteogenesis imperfecta mouse improves femoral geometry and load response before fracture but decreases predicted material properties and has detrimental effects on osteoblasts and bone formation. J Bone Miner Res 24:849–859PubMedCentralPubMedCrossRef
20.
Zurück zum Zitat Cabral WA, Marini JC (2004) High proportion of mutant osteoblasts is compatible with normal skeletal function in mosaic carriers of osteogenesis imperfecta. Am J Hum Genet 74:752–760PubMedCentralPubMedCrossRef Cabral WA, Marini JC (2004) High proportion of mutant osteoblasts is compatible with normal skeletal function in mosaic carriers of osteogenesis imperfecta. Am J Hum Genet 74:752–760PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat Le Blanc K, Gotherstrom C, Ringden O, Hassan M, McMahon R, Horwitz E, Anneren G, Axelsson O, Nunn J, Ewald U, Norden-Lindeberg S, Jansson M, Dalton A, Astrom E, Westgren M (2005) Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation 79:1607–1614PubMedCrossRef Le Blanc K, Gotherstrom C, Ringden O, Hassan M, McMahon R, Horwitz E, Anneren G, Axelsson O, Nunn J, Ewald U, Norden-Lindeberg S, Jansson M, Dalton A, Astrom E, Westgren M (2005) Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation 79:1607–1614PubMedCrossRef
22.
Zurück zum Zitat Jones GN, Moschidou D, Lay K, Abdulrazzak H, Vanleene M, Shefelbine SJ, Polak J, de Coppi P, Fisk NM, Guillot PV (2012) Upregulating CXCR4 in human fetal mesenchymal stem cells enhances engraftment and bone mechanics in a mouse model of osteogenesis imperfecta. Stem Cells Transl Med 1:70–78PubMedCentralPubMedCrossRef Jones GN, Moschidou D, Lay K, Abdulrazzak H, Vanleene M, Shefelbine SJ, Polak J, de Coppi P, Fisk NM, Guillot PV (2012) Upregulating CXCR4 in human fetal mesenchymal stem cells enhances engraftment and bone mechanics in a mouse model of osteogenesis imperfecta. Stem Cells Transl Med 1:70–78PubMedCentralPubMedCrossRef
23.
Zurück zum Zitat Kalajzic Z, Li H, Wang LP, Jiang X, Lamothe K, Adams DJ, Aguila HL, Rowe DW, Kalajzic I (2008) Use of an alpha-smooth muscle actin GFP reporter to identify an osteoprogenitor population. Bone 43:501–510PubMedCentralPubMedCrossRef Kalajzic Z, Li H, Wang LP, Jiang X, Lamothe K, Adams DJ, Aguila HL, Rowe DW, Kalajzic I (2008) Use of an alpha-smooth muscle actin GFP reporter to identify an osteoprogenitor population. Bone 43:501–510PubMedCentralPubMedCrossRef
24.
Zurück zum Zitat Li F, Wang X, Niyibizi C (2010) Bone marrow stromal cells contribute to bone formation following infusion into femoral cavities of a mouse model of osteogenesis imperfecta. Bone 47:546–555PubMedCentralPubMedCrossRef Li F, Wang X, Niyibizi C (2010) Bone marrow stromal cells contribute to bone formation following infusion into femoral cavities of a mouse model of osteogenesis imperfecta. Bone 47:546–555PubMedCentralPubMedCrossRef
25.
Zurück zum Zitat Pignolo RJ, Kassem M (2011) Circulating osteogenic cells: implications for injury, repair, and regeneration. J Bone Miner Res 26:1685–1693PubMedCrossRef Pignolo RJ, Kassem M (2011) Circulating osteogenic cells: implications for injury, repair, and regeneration. J Bone Miner Res 26:1685–1693PubMedCrossRef
Metadaten
Titel
Local transplantation is an effective method for cell delivery in the osteogenesis imperfecta murine model
verfasst von
Penelope Pauley
Brya G. Matthews
Liping Wang
Nathaniel A. Dyment
Igor Matic
David W. Rowe
Ivo Kalajzic
Publikationsdatum
01.09.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
International Orthopaedics / Ausgabe 9/2014
Print ISSN: 0341-2695
Elektronische ISSN: 1432-5195
DOI
https://doi.org/10.1007/s00264-013-2249-y

Weitere Artikel der Ausgabe 9/2014

International Orthopaedics 9/2014 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.